Procept biorobotics
PROCEPT BioRobotics is a surgical robotics company that develops and sells the AquaBeam Robotic System, an image-guided solution designed for minimally invasive urologic surgeries, primarily targeting benign prostatic hyperplasia (BPH).
Procept biorobotics Overview
Procept biorobotics Funding Rounds
Round | Date | Amount Raised | Valuation | Investors | Sources |
---|---|---|---|---|---|
IPO | 9/15/2021 | ||||
Series G | 6/17/2021 | ||||
Series F | 8/14/2020 | ||||
Series E | 2/21/2018 | ||||
Series D | 7/7/2015 | ||||
Series C | 10/15/2013 |
Procept biorobotics Investors
Investor | Investment Rounds | Lead Partner | Initial Investment | Other Notable Investments |
---|---|---|---|---|
Novo Holdings | Series D | Series D (2015-07-07) | ||
Viking Global Investors | Series E, Series F, Series G | Series E (2018-02-21) | ||
Fidelity Investments | Series G | Series G (2021-06-17) | ||
T. Rowe Price Group (NAS: TROW) | Series G | Series G (2021-06-17) |
Procept biorobotics 409a Valuations
Date | Price per share | Est. Valuation | Filling |
---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view |
Procept biorobotics Filings
Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Latest Procept biorobotics News
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
MSNOctober 21, 2024
PROCEPT BioRobotics Corporation (PRCT) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Yahoo FinanceOctober 21, 2024
PROCEPT BioRobotics (PRCT) Set to Announce Quarterly Earnings on Monday
MarketBeatOctober 21, 2024
Chicago Capital LLC Purchases 29,668 Shares of PROCEPT BioRobotics Co. (NASDAQ:PRCT)
MarketBeatOctober 20, 2024
Q3 EPS Forecast for PROCEPT BioRobotics Raised by Analyst
MarketBeatOctober 18, 2024
PROCEPT BioRobotics Co. (NASDAQ:PRCT) CFO Kevin Waters Sells 25,000 Shares
MarketBeatOctober 17, 2024
Marshall Wace LLP Purchases Shares of 9,283 PROCEPT BioRobotics Co. (NASDAQ:PRCT)
MarketBeatOctober 10, 2024
PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024
GlobeNewswireOctober 9, 2024